Commercial Quantities of Domestic Mo-99 in Late ‘23, NNSA Says

摘要

The National Nuclear Security Administration hopes its efforts to boost the domestic industry for Molybdenum-99 will resultin commercial-scale availability of the medical isotope a couple years from now, according to an annual nonproliferationreport the agency released before the holidays.Under its partnership with four U.S. companies the National Nuclear Security Administration (NNSA) “aims to increase Mo-99 produced by American companies and get commercial scale quantities of this critical medical isotope to market by theend of 2023,” according to the latest “Prevent, Counter, and Respond-NNSA’s Plan to Reduce Global Nuclear Threats”report.